<mods:mods version="3.3" xsi:schemaLocation="http://www.loc.gov/mods/v3 http://www.loc.gov/standards/mods/v3/mods-3-3.xsd" xmlns:mods="http://www.loc.gov/mods/v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"><mods:titleInfo><mods:title>COMPLICATIONS OF THE DISEASE IN PATIENTS WITH A HISTORY OF COVID-19</mods:title></mods:titleInfo><mods:name type="personal"><mods:namePart type="given">M. M. Yuldasheva</mods:namePart><mods:namePart type="family">M. M. Yuldasheva</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">E.N. Majidova</mods:namePart><mods:namePart type="family">E.N. Majidova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:name type="personal"><mods:namePart type="given">J.A. Nazarova</mods:namePart><mods:namePart type="family">J.A. Nazarova</mods:namePart><mods:role><mods:roleTerm type="text">author</mods:roleTerm></mods:role></mods:name><mods:abstract>This article discusses the complications of the disease in patients with a history of Covid-19. Severe severity according to the NIHSS scale was detected in 43.3% of patients with AT and 40.0% with CE, extreme severity was observed in 25.4% with AT and 36.4% with CE. Thus, severe IS at admission was detected in 36.6% of all examined patients and in 73.8% of patients with AT and CE subtypes of IS.</mods:abstract><mods:originInfo><mods:dateIssued encoding="iso8601">2023-04-16</mods:dateIssued></mods:originInfo><mods:genre>Maqola</mods:genre></mods:mods>